• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study bas

tetano

Editor, Senior Moderator
PLoS One


. 2023 Jan 4;18(1):e0266985.
doi: 10.1371/journal.pone.0266985. eCollection 2023.
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium


Bertrand Moal[SUP] 1 [/SUP], Arthur Orieux[SUP] 2 [/SUP], Thomas Ferté[SUP] 3 [/SUP], Antoine Neuraz[SUP] 4 [/SUP], Gabriel A Brat[SUP] 5 [/SUP], Paul Avillach[SUP] 5 [/SUP], Clara-Lea Bonzel[SUP] 5 [/SUP], Tianxi Cai[SUP] 5 [/SUP], Kelly Cho[SUP] 6 [/SUP], Sébastien Cossin[SUP] 7 [/SUP], Romain Griffier[SUP] 8 [/SUP], David A Hanauer[SUP] 9 [/SUP], Christian Haverkamp[SUP] 10 [/SUP], Yuk-Lam Ho[SUP] 8 [/SUP], Chuan Hong[SUP] 5 [/SUP], Meghan R Hutch[SUP] 11 [/SUP], Jeffrey G Klann[SUP] 12 [/SUP], Trang T Le[SUP] 5 [/SUP], Ne Hooi Will Loh[SUP] 13 [/SUP], Yuan Luo[SUP] 14 [/SUP], Adeline Makoudjou[SUP] 15 [/SUP], Michele Morris[SUP] 5 [/SUP], Danielle L Mowery[SUP] 5 [/SUP], Karen L Olson[SUP] 16 [/SUP], Lav P Patel[SUP] 14 [/SUP], Malarkodi J Samayamuthu[SUP] 5 [/SUP], Fernando J Sanz Vidorreta[SUP] 17 [/SUP], Emily R Schriver[SUP] 18 [/SUP], Petra Schubert[SUP] 19 [/SUP], Guillaume Verdy[SUP] 1 [/SUP], Shyam Visweswaran[SUP] 5 [/SUP], Xuan Wang[SUP] 5 [/SUP], Griffin M Weber[SUP] 5 [/SUP], Zongqi Xia[SUP] 20 [/SUP], William Yuan[SUP] 5 [/SUP], Harrison G Zhang[SUP] 5 [/SUP], Daniela Zöller[SUP] 21 [/SUP], Isaac S Kohane[SUP] 5 [/SUP]; Consortium for Clinical Characterization of COVID-19 by EHR (4CE); Alexandre Boyer[SUP] 2 [/SUP], Vianney Jouhet[SUP] 8 [/SUP]



Affiliations

Abstract

Purpose: In young adults (18 to 49 years old), investigation of the acute respiratory distress syndrome (ARDS) after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been limited. We evaluated the risk factors and outcomes of ARDS following infection with SARS-CoV-2 in a young adult population.
Methods: A retrospective cohort study was conducted between January 1st, 2020 and February 28th, 2021 using patient-level electronic health records (EHR), across 241 United States hospitals and 43 European hospitals participating in the Consortium for Clinical Characterization of COVID-19 by EHR (4CE). To identify the risk factors associated with ARDS, we compared young patients with and without ARDS through a federated analysis. We further compared the outcomes between young and old patients with ARDS.
Results: Among the 75,377 hospitalized patients with positive SARS-CoV-2 PCR, 1001 young adults presented with ARDS (7.8% of young hospitalized adults). Their mortality rate at 90 days was 16.2% and they presented with a similar complication rate for infection than older adults with ARDS. Peptic ulcer disease, paralysis, obesity, congestive heart failure, valvular disease, diabetes, chronic pulmonary disease and liver disease were associated with a higher risk of ARDS. We described a high prevalence of obesity (53%), hypertension (38%- although not significantly associated with ARDS), and diabetes (32%).
Conclusion: Trough an innovative method, a large international cohort study of young adults developing ARDS after SARS-CoV-2 infection has been gather. It demonstrated the poor outcomes of this population and associated risk factor.
 
Back
Top Bottom